Intestinal permeability in patients undergoing stem cell transplantation correlates with systemic acute phase responses and dysbiosis

Key Points • L:R ratios rise after conditioning, independent of regimen or diagnosis, and return to baseline by day +30 in most patients receiving allogeneic HSCT.• Intestinal permeability correlates directly with LBP levels and inversely with dysbiosis.

[1]  R. Heaton,et al.  Markers of Gut Barrier Function and Microbial Translocation Associate with Lower Gut Microbial Diversity in People with HIV , 2021, Viruses.

[2]  Yan-ping Xu,et al.  Antibiotic exposure prevents acquisition of beneficial metabolic functions in the preterm infant gut microbiome , 2021, Microbiome.

[3]  A. Oturai,et al.  Circulating levels of tight junction proteins in multiple sclerosis: Association with inflammation and disease activity before and after disease modifying therapy. , 2021, Multiple sclerosis and related disorders.

[4]  M. V. D. van den Brink,et al.  The post-hematopoietic cell transplantation microbiome: relationships with transplant outcome and potential therapeutic targets , 2021, Haematologica.

[5]  M. Norkin,et al.  Phase II Trial of Costimulation Blockade With Abatacept for Prevention of Acute GVHD , 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  Y. Taur,et al.  Fecal microbiota diversity disruption and clinical outcomes after auto-HCT: a multicenter observational study. , 2020, Blood.

[7]  A. Lasek-Bal,et al.  Plasma Levels of Occludin and Claudin-5 in Acute Stroke Are Correlated with the Type and Location of Stroke but Not with the Neurological State of Patients—Preliminary Data , 2020, Brain sciences.

[8]  Xinyan Zhang,et al.  NBZIMM: negative binomial and zero-inflated mixed models, with application to microbiome/metagenomics data analysis , 2020, BMC Bioinform..

[9]  N. Yi,et al.  NBZIMM: negative binomial and zero-inflated mixed models, with application to microbiome/metagenomics data analysis , 2020, BMC Bioinformatics.

[10]  Jingjing Fu,et al.  Microbial tryptophan metabolites regulate gut barrier function via the aryl hydrocarbon receptor , 2020, Proceedings of the National Academy of Sciences.

[11]  S. Davies,et al.  Graft Versus Host Disease Prophylaxis With Abatacept Reduces Severe Acute Graft Versus Host Disease in Allogeneic Hematopoietic Stem Cell Transplant for Beta Thalassemia Major with Busulfan, Fludarabine, and Thiotepa. , 2020, Transplantation.

[12]  N. Lu,et al.  Role of gut microbiota on intestinal barrier function in acute pancreatitis , 2020, World journal of gastroenterology.

[13]  Daigo Hashimoto,et al.  Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation. , 2020, The New England journal of medicine.

[14]  Y. Taur,et al.  Compositional flux within the intestinal microbiota and risk for bloodstream infection with gram-negative bacteria. , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  Ranjit S. Chima,et al.  Complement blockade for TA-TMA: lessons learned from large pediatric cohort treated with eculizumab. , 2020, Blood.

[16]  Amanda J. Pickard,et al.  Lactose drives Enterococcus expansion to promote graft-versus-host disease , 2019, Science.

[17]  J. Lallès.  Recent advances in intestinal alkaline phosphatase, inflammation, and nutrition. , 2019, Nutrition reviews.

[18]  Alexandra J. Roth-Schulze,et al.  Gut microbiome dysbiosis and increased intestinal permeability in children with islet autoimmunity and type 1 diabetes: A prospective cohort study , 2019, Pediatric diabetes.

[19]  V. Bucci,et al.  Gut Colonization Preceding Mucosal Barrier Injury Bloodstream Infection in Pediatric Hematopoietic Stem Cell Transplant Recipients. , 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[20]  A. Fasano,et al.  Breaking Down Barriers: How Understanding Celiac Disease Pathogenesis Informed the Development of Novel Treatments , 2019, Digestive Diseases and Sciences.

[21]  P. Nighot,et al.  Lipopolysaccharide-Induced Increase in Intestinal Permeability Is Mediated by TAK-1 Activation of IKK and MLCK/MYLK Gene. , 2019, The American journal of pathology.

[22]  D. Xiao,et al.  Vitamin A inhibits the action of LPS on the intestinal epithelial barrier function and tight junction proteins. , 2019, Food & function.

[23]  J. Turner,et al.  Graft-versus-host disease propagation depends on increased intestinal epithelial tight junction permeability , 2019, The Journal of clinical investigation.

[24]  K. Akashi,et al.  Gastrointestinal Graft-versus-Host Disease Is a Risk Factor for Postengraftment Bloodstream Infection in Allogeneic Hematopoietic Stem Cell Transplant Recipients. , 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[25]  M. V. D. van den Brink,et al.  Survival signal REG3&agr; prevents crypt apoptosis to control acute gastrointestinal graft-versus-host disease , 2018, The Journal of clinical investigation.

[26]  N. Kröger,et al.  MAGIC biomarkers predict long-term outcomes for steroid-resistant acute GVHD. , 2018, Blood.

[27]  A. Griffiths,et al.  Human ALPI deficiency causes inflammatory bowel disease and highlights a key mechanism of gut homeostasis , 2018, EMBO molecular medicine.

[28]  P. Nighot,et al.  Lipopolysaccharide-Induced Increase in Intestinal Epithelial Tight Permeability Is Mediated by Toll-Like Receptor 4/Myeloid Differentiation Primary Response 88 (MyD88) Activation of Myosin Light Chain Kinase Expression. , 2017, The American journal of pathology.

[29]  Yinglin Xia,et al.  Hypothesis testing and statistical analysis of microbiome , 2017, Genes & diseases.

[30]  A. Fasano,et al.  Zonulin transgenic mice show altered gut permeability and increased morbidity/mortality in the DSS colitis model , 2017, Annals of the New York Academy of Sciences.

[31]  S. Davies,et al.  Lower levels of vitamin A are associated with increased gastrointestinal graft-versus-host disease in children. , 2017, Blood.

[32]  D. Burton,et al.  13C mannitol as a novel biomarker for measurement of intestinal permeability , 2016, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[33]  M. Camilleri,et al.  Improving the detection of environmental enteric dysfunction: a lactulose, rhamnose assay of intestinal permeability in children aged under 5 years exposed to poor sanitation and hygiene , 2016, BMJ Global Health.

[34]  Laura M Cox,et al.  Alterations of the human gut microbiome in multiple sclerosis , 2016, Nature Communications.

[35]  R. Hodin,et al.  Intestinal Alkaline Phosphatase Regulates Tight Junction Protein Levels. , 2016, Journal of the American College of Surgeons.

[36]  Gabriel A. Al-Ghalith,et al.  Pretreatment gut microbiome predicts chemotherapy-related bloodstream infection , 2016, Genome Medicine.

[37]  G. Hong,et al.  Prognostic Value of Plasma Tight-Junction Proteins for Sepsis in Emergency Department: an Observational Study , 2016, Shock.

[38]  Corinne Rossi,et al.  Gut microbiome derived metabolites modulate intestinal epithelial cell damage and mitigate Graft-versus-Host Disease , 2016, Nature Immunology.

[39]  P. Nighot,et al.  Lipopolysaccharide Regulation of Intestinal Tight Junction Permeability Is Mediated by TLR4 Signal Transduction Pathway Activation of FAK and MyD88 , 2015, The Journal of Immunology.

[40]  Jie Du,et al.  1,25-Dihydroxyvitamin D Protects Intestinal Epithelial Barrier by Regulating the Myosin Light Chain Kinase Signaling Pathway , 2015, Inflammatory bowel diseases.

[41]  Y. Taur,et al.  Intestinal Blautia Is Associated with Reduced Death from Graft-versus-Host Disease. , 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[42]  J. Turner,et al.  Intestinal barrier loss as a critical pathogenic link between inflammatory bowel disease and graft-versus-host disease , 2015, Mucosal Immunology.

[43]  S. Rampelli,et al.  Gut microbiota trajectory in pediatric patients undergoing hematopoietic SCT , 2015, Bone Marrow Transplantation.

[44]  K. Bennett,et al.  Effects of vitamin D supplementation on intestinal permeability, cathelicidin and disease markers in Crohn’s disease: Results from a randomised double-blind placebo-controlled study , 2015, United European gastroenterology journal.

[45]  J. Millán,et al.  A Novel Approach to Maintain Gut Mucosal Integrity Using an Oral Enzyme Supplement , 2014, Annals of surgery.

[46]  A. Viale,et al.  The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation. , 2014, Blood.

[47]  Daniel Wolff,et al.  Metagenomic analysis of the stool microbiome in patients receiving allogeneic stem cell transplantation: loss of diversity is associated with use of systemic antibiotics and more pronounced in gastrointestinal graft-versus-host disease. , 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[48]  Derrick E. Wood,et al.  Kraken: ultrafast metagenomic sequence classification using exact alignments , 2014, Genome Biology.

[49]  S. Massart,et al.  16S rRNA Gene Pyrosequencing Reveals Shift in Patient Faecal Microbiota During High-Dose Chemotherapy as Conditioning Regimen for Bone Marrow Transplantation , 2014, Microbial Ecology.

[50]  M. Tomita,et al.  Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells , 2013, Nature.

[51]  T. Braun,et al.  ST2 as a marker for risk of therapy-resistant graft-versus-host disease and death. , 2013, The New England journal of medicine.

[52]  H. Said,et al.  Lipopolysaccharide causes an increase in intestinal tight junction permeability in vitro and in vivo by inducing enterocyte membrane expression and localization of TLR-4 and CD14. , 2013, The American journal of pathology.

[53]  A. Fasano.  Intestinal permeability and its regulation by zonulin: diagnostic and therapeutic implications. , 2012, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[54]  N. Socci,et al.  Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantation. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[55]  J. Bowen,et al.  Chemotherapy-induced gut toxicity: are alterations to intestinal tight junctions pivotal? , 2012, Cancer Chemotherapy and Pharmacology.

[56]  R. Khanin,et al.  Regulation of intestinal inflammation by microbiota following allogeneic bone marrow transplantation , 2012, The Journal of experimental medicine.

[57]  Thomas M Braun,et al.  Regenerating islet-derived 3-alpha is a biomarker of gastrointestinal graft-versus-host disease. , 2011, Blood.

[58]  S. Lecleire,et al.  The Expression and the Cellular Distribution of the Tight Junction Proteins Are Altered in Irritable Bowel Syndrome Patients With Differences According to the Disease Subtype , 2011, The American Journal of Gastroenterology.

[59]  P. Rutgeerts,et al.  Effects of haptoglobin polymorphisms and deficiency on susceptibility to inflammatory bowel disease and on severity of murine colitis , 2011, Gut.

[60]  M. Washington,et al.  Colon-specific delivery of a probiotic-derived soluble protein ameliorates intestinal inflammation in mice through an EGFR-dependent mechanism. , 2011, The Journal of clinical investigation.

[61]  Hsien-Bin Huang,et al.  Haptoglobin Polymorphism as a Risk Factor for Chronic Kidney Disease: A Case-Control Study , 2011, American Journal of Nephrology.

[62]  A. Watson,et al.  The epithelial barrier is maintained by in vivo tight junction expansion during pathologic intestinal epithelial shedding. , 2011, Gastroenterology.

[63]  A. Fasano,et al.  Identification of human zonulin, a physiological modulator of tight junctions, as prehaptoglobin-2 , 2009, Proceedings of the National Academy of Sciences.

[64]  S. Zeissig,et al.  Epithelial Tight Junctions in Intestinal Inflammation , 2009, Annals of the New York Academy of Sciences.

[65]  D. Rubin,et al.  Claudin-1 and claudin-2 expression is elevated in inflammatory bowel disease and may contribute to early neoplastic transformation , 2008, Laboratory Investigation.

[66]  G. Veres,et al.  Haptoglobin polymorphism: a novel genetic risk factor for celiac disease development and its clinical manifestations. , 2008, Clinical chemistry.

[67]  Kyle R. Eberlin,et al.  Intestinal alkaline phosphatase is a gut mucosal defense factor maintained by enteral nutrition , 2008, Proceedings of the National Academy of Sciences.

[68]  J. Johansson,et al.  Gut Toxicity During Hemopoietic Stem Cell Transplantation May Predict Acute Graft-Versus-Host Disease Severity in Patients , 2007, Digestive Diseases and Sciences.

[69]  M. Washington,et al.  Soluble proteins produced by probiotic bacteria regulate intestinal epithelial cell survival and growth. , 2007, Gastroenterology.

[70]  U Wahnschaffe,et al.  Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn’s disease , 2006, Gut.

[71]  Dario Iafusco,et al.  Zonulin Upregulation Is Associated With Increased Gut Permeability in Subjects With Type 1 Diabetes and Their Relatives , 2006, Diabetes.

[72]  W. Seinen,et al.  Calf Intestinal Alkaline Phosphatase, a Novel Therapeutic Drug for Lipopolysaccharide (LPS)-Mediated Diseases, Attenuates LPS Toxicity in Mice and Piglets , 2003, Journal of Pharmacology and Experimental Therapeutics.

[73]  H. Groen,et al.  Lipopolysaccharide-binding protein: a possible diagnostic marker for Gram-negative bacteremia in neutropenic cancer patients , 2003, Intensive Care Medicine.

[74]  D. Korenaga,et al.  Assessment of the Intestinal Permeability following Postoperative Chemotherapy for Human Malignant Disease , 2003, European Surgical Research.

[75]  P. Laterre,et al.  Lipopolysaccharide-binding protein serum levels in patients with severe sepsis due to gram-positive and fungal infections. , 2003, The Journal of infectious diseases.

[76]  T. Ekman,et al.  The gut mucosa barrier is preserved during allogeneic, haemopoietic stem cell transplantation with reduced intensity conditioning , 2001, Bone Marrow Transplantation.

[77]  A. Cummins,et al.  Chemotherapy for cancer causes apoptosis that precedes hypoplasia in crypts of the small intestine in humans , 2000, Gut.

[78]  R. Schumann,et al.  A Novel Acute-Phase Marker: Lipopolysaccharide Binding Protein (LBP) , 1999, Clinical chemistry and laboratory medicine.

[79]  J. Schulzke,et al.  Altered tight junction structure contributes to the impaired epithelial barrier function in ulcerative colitis. , 1999, Gastroenterology.

[80]  A. Wåhlin,et al.  Intestinal permeability in patients with acute myeloid leukemia , 1998, European journal of haematology.

[81]  K. Hirata,et al.  Bacterial lipopolysaccharide reduced intestinal barrier function and altered localization of 7H6 antigen in IEC‐6 rat intestinal crypt cells , 1997, Journal of Cellular Physiology.

[82]  T. Ekman,et al.  Gastro-intestinal toxicity related to bone marrow transplantation: disruption of the intestinal barrier precedes clinical findings , 1997, Bone Marrow Transplantation.

[83]  A. Cummins,et al.  Effect of high-dose chemotherapy on intestinal permeability in humans. , 1997, Clinical science.

[84]  A. Macpherson,et al.  Intestinal permeability: an overview. , 1995, Gastroenterology.

[85]  C. Fegan,et al.  The gut mucosal barrier in bone marrow transplantation. , 1990, Bone marrow transplantation.

[86]  S. Geller,et al.  A freeze fracture study of Crohn's disease of the terminal ileum: changes in epithelial tight junction organization. , 1983, The American journal of gastroenterology.

[87]  T. Braun,et al.  A prognostic score for acute graft-versus-host disease based on biomarkers: a multicentre study. , 2015, The Lancet. Haematology.

[88]  G. Ning,et al.  Novel role of the vitamin D receptor in maintaining the integrity of the intestinal mucosal barrier. , 2008, American journal of physiology. Gastrointestinal and liver physiology.

[89]  J. Schulzke,et al.  Tumor necrosis factor-alpha (TNFalpha) regulates the epithelial barrier in the human intestinal cell line HT-29/B6. , 1999, Journal of cell science.

[90]  S. Erlandsen,et al.  Effect of LPS on epithelial integrity and bacterial uptake in the polarized human enterocyte-like cell line Caco-2. , 1993, Circulatory shock.

[91]  G. Su,et al.  Induction of hepatocyte lipopolysaccharide binding protein in models of sepsis and the acute-phase response. , 1993, Archives of surgery.